Provided by Tiger Trade Technology Pte. Ltd.

Alamar Biosciences

26.32
-1.4500-5.22%
Volume:589.64K
Turnover:15.44M
Market Cap:1.82B
PE:-36.76
High:28.07
Open:28.05
Low:25.39
Close:27.77
52wk High:39.61
52wk Low:18.85
Shares:69.31M
Float Shares:12.94M
Volume Ratio:1.16
T/O Rate:4.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7160
EPS(LYR):-2.5873
ROE:-33.57%
ROA:-13.53%
PB:5.83
PE(LYR):-10.17

Loading ...

Alamar Biosciences Names Former GRAIL CEO Bob Ragusa to Board

Reuters
·
Oct 06

Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team

THOMSON REUTERS
·
Oct 06

Nightingale Health Signs USD 6.5 Million Proteomics Services Deal with Michael J. Fox Foundation

Reuters
·
Oct 01

Lancet study using Alamar’s technology reveals divergent responses to Alzheimers

TIPRANKS
·
Sep 25

Alamar Biosciences Says Lancet Neurology Study Tracks 130 Plasma Biomarkers in Real-World Lecanemab-Treated Alzheimer’s Patients

Reuters
·
Sep 25

Lancet Neurology Study Using Alamar Biosciences’ Technology Reveals Divergent Biological Responses to Alzheimer’s Treatment

THOMSON REUTERS
·
Sep 25

US Research Roundup-Autozone, General Mills, JPMorgan

Reuters
·
Sep 24

Alamar Biosciences Inc : Leerink Partners Raises Target Price to $45 from $35

THOMSON REUTERS
·
Sep 24

Alamar Biosciences rises 9.4%

TIPRANKS
·
Sep 18

Alamar Biosciences Director Robert P. Ragusa Files Initial Beneficial Ownership Statement

Reuters
·
Sep 04

Alamar Biosciences Appoints Robert Ragusa to Board

Reuters
·
Sep 02

Alamar Biosciences Price Target Raised to $32.00/Share from $28.00 by Stifel

Dow Jones
·
Aug 12

Top Midday Gainers

MT Newswires Live
·
Aug 12

Alamar Biosciences Stock Soars, CEO Says Company Is Well-Positioned to Sustain Upcoming Momentum

Benzinga Earnings
·
Aug 12

Alamar Biosciences up over 18%, on Track for Record High Close and Record Percent Increase

Dow Jones
·
Aug 11

BofA Adjusts Price Target on Alamar Biosciences to $31 From $30

MT Newswires Live
·
Aug 11

Alamar Biosciences price target raised to $32 from $28 at Stifel

TIPRANKS
·
Aug 11

U.S. Research Roundup-Accendra Health, Celestica, Sionna Therapeutics

Reuters
·
Aug 11

Alamar Biosciences Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11

Alamar Biosciences Outlook FY Revenue $116 Mln-$120 Mln

THOMSON REUTERS
·
Aug 11